en

PRODUCT DETAIL

Cimzia 200 mg injekčný roztok v náplni do dávkovacieho zariadenia

Code 7142C
MA number EU/1/09/544/009
Product Form: sol inj 6(3x2)x1 ml/200 mg (náplň do dávk.zar.+2 lieh.tamp.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB05 Certolizumab pegol
Shelf life: 24
Container: glass pre-filled syringe
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 01.10.2009
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.05.2019
eu-flag.png sk-flag.png